Despite early reports of suppressed IFN production, there is emerging evidence that patients with severe COVID-19 have a sustained type I IFN response that contrasts with the delayed, possibly suppressed, interferon response seen early on during infection [42]. This evidence concerns the gene IFNA1 and COVID-19.